<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04834817</url>
  </required_header>
  <id_info>
    <org_study_id>2021-6401</org_study_id>
    <nct_id>NCT04834817</nct_id>
  </id_info>
  <brief_title>Effect of Combined Red and Near Infrared Light-emitting Diode (LED) Therapy on Tissue Regeneration Post Laser Treatment</brief_title>
  <official_title>The Effect of Combined Red and Near Infrared Light-emitting Diode (LED) Therapy on Tissue Regeneration Post Laser Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BioPhotas</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of light therapy on wound healing after&#xD;
      laser treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study sets out to evaluate the effect of a combination of near infrared (830 nm) red&#xD;
      (633 nm) and blue (465nm) light-emitting diode (LED) therapy on wound healing after laser&#xD;
      application.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Days to healing</measure>
    <time_frame>56 days</time_frame>
    <description>The primary endpoint of this study is time and days to complete healing of the treatment sites. Clinical grading shall be by blinded assessment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain level</measure>
    <time_frame>56 days</time_frame>
    <description>A secondary outcome measure will be post-treatment pain on a 11-point Lickert scale from 0-10. Higher scores mean a worse outcome.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Wound Heal</condition>
  <arm_group>
    <arm_group_label>LED treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LED treatment with Celluma POD device after laser test area</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No treatment after laser test area</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Celluma POD</intervention_name>
    <description>A blue and near infrared handheld LED device</description>
    <arm_group_label>LED treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Adults aged 18 years or older with no active cutaneous disease on bilateral ventral biceps,&#xD;
        close to the axilla.&#xD;
&#xD;
        Subjects shall have given written informed consent for both the LED therapy and for&#xD;
        clinical photography.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients will be excluded if any of the exclusion criteria applies&#xD;
&#xD;
          -  Subjects refuse to give informed consent for either the phototherapy or the clinical&#xD;
             photography.&#xD;
&#xD;
          -  Subjects have previous photosensitivity problems (solar urticaria, etc.).&#xD;
&#xD;
          -  Subjects are taking any systemic drug or applying any topical drug with known&#xD;
             photosensitizing properties.&#xD;
&#xD;
          -  Subjects taking any systemic drug with known immunosuppressant properties.&#xD;
&#xD;
          -  Subjects applying any medications to the research site (inner biceps, close to the&#xD;
             axilla).&#xD;
&#xD;
          -  Subjects have medical or psychosocial conditions associated with a risk of poor&#xD;
             protocol compliance.&#xD;
&#xD;
          -  Subjects are smokers or have smoked within the last 30 days prior to the trial.&#xD;
&#xD;
          -  Subjects have epilepsy or a history of seizures&#xD;
&#xD;
          -  Subjects currently taking cortisone injections or any other kind of steroid&#xD;
             injections(s)&#xD;
&#xD;
          -  Subjects with known cancer tumor in the treatment area or metastasis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristen Kelly, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Irvine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hanna Kim, MA</last_name>
    <phone>949-824-9265</phone>
    <email>hhkim3@uci.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCI Beckman Laser Institute and Medical Clinic</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92697</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanna Kim, MA</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 4, 2021</study_first_submitted>
  <study_first_submitted_qc>April 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2021</study_first_posted>
  <last_update_submitted>April 7, 2021</last_update_submitted>
  <last_update_submitted_qc>April 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Kristen Kelly</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

